Other headlines for [SLXP]

• SLXP 11/18/2008 12:31pm
  Salix Pharmaceuticals Ltd FDA extends review date by three months for Metozol- SLXP says extension has no impact on its previously announced financial guidance for 2008
  
• SLXP 11/18/2008 11:00am
  Salix Pharmaceuticals Ltd Announces issuance of U.S. Patent for Rifaximin- Provides protection relating to rifaximin for treating irritable bowel syndrome (IBS) caused by small intestinal bacterial overgrowth. - Salix has more...
  
• SLXP 11/5/2008 04:02pm
  Salix Pharmaceuticals Ltd Reports Q3 -$0.11 v -$0.31e, R $42.9M v $43.6Me- Guides FY08 -$0.90 v -$1.05e, R$178-180M v $176.3Me - Cash and cash equivalents were $121.9M on September 30, 2008.
  
• SLXP 10/31/2008 03:53pm
  Salix Pharmaceuticals Ltd APRISO Granted FDA Marketing Approval for Maintenance of Remission of Ulcerative Colitis- APRISO is the first and only 5-ASA with Intellicor extended release delivery technology. - The Company more...
  
• SLXP 10/9/2008 01:13pm
  Salix Pharmaceuticals Ltd Block of 1M shares trades at $7.00
  

Healthcare sector headlines

• MYL Today 07:30am
  Mylan Laboratories Inc Announces settlement agreement with Novartis related to Femara First- to-File Opportunity- Under the agreement, Mylan is provided a patent license that will enable the company to market Letrozole more...
  
• XNPT Today 07:30am
  XenoPort Inc Reports Results from a Phase 2 Clinical Trial of XP19986 as a Treatment for the Symptoms of Gastroesophageal Reflux Disease- The primary analysis comparing XP19986 to placebo did not reach more...
  
• TGEN Today 07:30am
  Targeted Genetics Corp Realigns product development priorities;Implements cost reduction measures- Ealigned its product development priorities to focus on its ocular and neurological product candidates and its first use of more...
  
• XNPT Today 07:27am
  XenoPort Inc Halted: News pending
  
• SVA Today 07:04am
  Sinovac Biotech Releases statement on Sinovac vaccine suspension- Health Services Bureau of Fengtai District in the City of Beijing suspended the use of 83 doses of inactivated hepatitis A vaccine Healive(R), more...